Rodman & Renshaw Cuts Medivation (MDVN) to Market Underperform, Sets $13 Price Target

April 11, 2011 11:53 AM EDT Send to a Friend
An analyst at Rodman & Renshaw downgraded shares of Medivation (Nasdaq: MDVN) from Market Perform to Market Underperform Monday morning ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login